Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Akbar Dorgalaleh, Shadi Tabibian, Maryam Sadat Hosseini & Mahmood Shams. (2020) Pharmacological management of rare coagulation factor deficiencies besides hemophilia. Expert Review of Hematology 13:8, pages 811-834.
Read now
Read now
Allison P. Wheeler, Celeste Hemingway & David Gailani. (2020) The clinical management of factor XI deficiency in pregnant women. Expert Review of Hematology 13:7, pages 719-729.
Read now
Read now
Bassem M. Mohammed, Dougald M. Monroe & David Gailani. (2020) Mouse models of hemostasis. Platelets 31:4, pages 417-422.
Read now
Read now
Anouk J. W. Gulpen, Arina J. Ten Cate-Hoek & Hugo Ten Cate. (2016) Upstream versus downstream thrombin inhibition. Expert Review of Cardiovascular Therapy 14:11, pages 1273-1282.
Read now
Read now
Articles from other publishers (70)
Matthew B. Smolkin & Aaron D. Shmookler. 2024. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
241
253
.
Kamran Bakhtiari & Joost C.M. Meijers. (2023) Reversal of factor XI targeting anticoagulants: an in vitro evaluation. Journal of Thrombosis and Haemostasis.
Crossref
Crossref
Tomoki Kato, Michihiro Yamada, Takuma Watanabe, Shigeki Yamanaka, Shizuko Fukuhara & Kazumasa Nakao. (2023) Congenital factor XI deficiency with multiple tooth extractions (Case report). Experimental and Therapeutic Medicine 26:5.
Crossref
Crossref
Alfred Jones, Dawn Swan, Ton Lisman, Geoffrey D. Barnes & Jecko Thachil. (2023) Anticoagulation in chronic kidney disease: current status and future perspectives. Journal of Thrombosis and Haemostasis.
Crossref
Crossref
John Puetz & Brian Hu. (2023) Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdataset. Pediatric Blood & Cancer.
Crossref
Crossref
Maria Cristina Vedovati, Cecilia Becattini & Giancarlo Agnelli. (2023) A new strategy for anticoagulation: The factor XI inhibitors. European Journal of Internal Medicine.
Crossref
Crossref
Surasak Wichaiyo, Warisara Parichatikanond, Satsawat Visansirikul, Nakkawee Saengklub & Wipharak Rattanavipanon. (2023) Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis. ACS Pharmacology & Translational Science 6:7, pages 970-981.
Crossref
Crossref
Belén de la Morena-Barrio, Ángeles Palomo, José Padilla, Laura Martín-Fernández, Juan José Rojo-Carrillo, Rosa Cifuentes, Carlos Bravo-Pérez, Pedro Garrido-Rodríguez, Antonia Miñano, Ana María Rubio, Javier Pagán, María Llamas, Vicente Vicente, Francisco Vidal, María Luisa Lozano, Javier Corral & María Eugenia de la Morena-Barrio. (2023) Impact of genetic structural variants in factor XI deficiency: identification, accurate characterization, and inferred mechanism by long-read sequencing. Journal of Thrombosis and Haemostasis 21:7, pages 1779-1788.
Crossref
Crossref
James S. Tweddell, Mousa Kharnaf, Farhan Zafar, Kyle W. Riggs, James A. Reagor, Brett P. Monia, Alexey Revenko, Daniel G. Leino, A. Phillip OwensIIIIII, Janine K. Martin, Benjamin Gourley, Leah Rosenfeldt & Joseph S. Palumbo. (2023) Targeting the contact system in a rabbit model of extracorporeal membrane oxygenation. Blood Advances 7:8, pages 1404-1417.
Crossref
Crossref
Sara Kianian, Giacomo Scorsese, Eric Zabirowicz & Jeremy Poppers. (2023) Perioperative Management of a Patient with Hemophilia C and Allergy to Fresh Frozen Plasma. Case Reports in Anesthesiology 2023, pages 1-4.
Crossref
Crossref
Mehmet Gurcan, Serdar Turan, Ebru Demirel & Senol Tonyali. (2023) How to Deal With Hemophilia C in Endoscopic Urologic Surgery: Lessons Learned From a Transurethral Resection of Bladder Tumor Case. Cureus.
Crossref
Crossref
Stéphanie E. Reitsma, Lori A. Holle, Emma G. Bouck, Dougald M. Monroe, Alan E. Mast, John Burthem, Paula H.B. Bolton-Maggs, Gillian N. Gidley & Alisa S. Wolberg. (2023) Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency. Journal of Thrombosis and Haemostasis 21:3, pages 467-479.
Crossref
Crossref
Mark T. Friedman, Kamille A. West, Peyman Bizargity, Kyle Annen, H. Deniz Gur & Timothy HilbertMark T. Friedman, Kamille A. West, Peyman Bizargity, Kyle Annen, H. Deniz Gur & Timothy Hilbert. 2023. Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy. Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy
529
533
.
Omri Cohen & Walter Ageno. (2022) Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism. Hematology 2022:1, pages 495-505.
Crossref
Crossref
Yang Cao & Aldons J. Lusis. (2022) Coagulation factor with potential for the treatment of heart failure. Clinical and Translational Medicine 12:12.
Crossref
Crossref
Joeliton S. Cavalcante, Weslley Ruan G. Borges da Silva, Laudicéia Alves de Oliveira, Ingrid Mayara C. Brito, Kevin S. Muller, Ivynna Suellen J. Vidal, Lucilene Delazari dos Santos, Roberta Jeane Bezerra Jorge, Cayo Almeida & Carla de Lima Bicho. (2022) Blood plasma proteome alteration after local tissue damage induced by Bothrops erythromelas snake venom in mice. Journal of Proteomics 269, pages 104742.
Crossref
Crossref
Yang Cao, Yuchen WangZhenqi Zhou, Calvin Pan, Ling Jiang, Zhiqiang ZhouYonghong MengSarada CharugundlaTao Li, Hooman Allayee, Marcus M. SeldinAldons J. Lusis. (2022) Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure. Science 377:6613, pages 1399-1406.
Crossref
Crossref
Reiner K. Mailer & Thomas Renné. (2022) Commentary on “Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa”: Small molecule factor XIa inhibitor asundexian allows for safer anticoagulation. Journal of Thrombosis and Haemostasis 20:6, pages 1309-1311.
Crossref
Crossref
V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, I. A. Nakaidze, I. Elalamy, J.-C. Gris & A. D. Makatsariya. (2022) Anticoagulants: dose control methods and inhibitors. Obstetrics, Gynecology and Reproduction 16:2, pages 158-175.
Crossref
Crossref
Joseph P. Marshalek, David Yashar, Karen Huynh & Sarah Tomassetti. (2022) Case of concurrent factor VII and factor XI deficiencies manifesting as spontaneous lower extremity compartment syndrome. Clinical Case Reports 10:4.
Crossref
Crossref
David Gailani. (2022) Factor XI as a target for preventing venous thromboembolism. Journal of Thrombosis and Haemostasis 20:3, pages 550-555.
Crossref
Crossref
Assaf Arie Barg, Sarina Levy‐Mendelovich, Ivan Budnik, Noa Mandel‐Shorer, Rima Dardik, Einat Avishai, Tami Brutman‐Barazani, Aviya Dvir Ifrah, Liat Oren‐Malek, Joanne Yacobovich, Oded Gilad, Sigal Nakav, Yariv Fruchtman, Shoshana Revel‐Vilk, Hagit Miskin & Gili Kenet. (2021) Pediatric severe factor XI deficiency: A multicenter study. Pediatric Blood & Cancer 69:3.
Crossref
Crossref
Shravan Morla, Hiroshi Deguchi, Jevgenia Zilberman-Rudenko, András Gruber, Owen J.T. McCarty, Priyanka Srivastava, David Gailani & John H. Griffin. (2022) Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation. Journal of Biological Chemistry 298:2, pages 101567.
Crossref
Crossref
Wen-Juan Guo, Wei-Yun Chen, Xue-Rong Yu, Le Shen & Yu-Guang Huang. (2022) Intraoperative thromboelastography-guided transfusion in a patient with factor XI deficiency: A case report. World Journal of Clinical Cases 10:1, pages 242-248.
Crossref
Crossref
Heiko Rühl, Anne M. Friemann, Sara Reda, Nadine Schwarz, Franziska I. Winterhagen, Christina Berens, Jens Müller, Johannes Oldenburg & Bernd Pötzsch. (2022) Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation. Journal of Atherosclerosis and Thrombosis 29:1, pages 82-98.
Crossref
Crossref
Keiji NOGAMI. (2022) Diagnosis and treatment on rare bleeding disorders (RBD)希少出血性疾患（Rare bleeding disorders）の診断と治療. Japanese Journal of Thrombosis and Hemostasis 33:1, pages 45-52.
Crossref
Crossref
Ting Yang, Jin Zhu, Xiuhua Chen, Fengping Wang, Xiaoyan Zheng & Xiaoli Cheng. (2022) Detection and Gene Mutation Analysis of Three Variations in Two Unrelated Chinese Hereditary Coagulation Factor XI Deficiency Families. Acta Haematologica 145:6, pages 611-618.
Crossref
Crossref
Ophira Salomon & David Gailani. (2022) A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors. Journal of Thrombosis and Haemostasis 20:1, pages 32-38.
Crossref
Crossref
Huanhuan Wang, Shuting Jiang, Haixiao Xie, Lihong Yang, Yanhui Jin & Mingshan Wang. (2022) Genetic analysis of compound heterozygous pathogenic variants of the F11 gene in two Chinese patients with hereditary factor XI deficiency. Blood Coagulation & Fibrinolysis 33:1, pages 61-66.
Crossref
Crossref
Ru Yin & Chen Liu. (2022) Human coagulation factor IX: a systematic review of its characteristics. Blood Coagulation & Fibrinolysis 33:1, pages 1-7.
Crossref
Crossref
Li Yuan, Wei Chen, Xiaoqin Wang & Heng Zhang. (2021) Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China. Blood Coagulation & Fibrinolysis 32:8, pages 539-543.
Crossref
Crossref
John Eikelboom, Jürgen Floege, Ravi Thadhani, Jeffrey I. Weitz & Wolfgang C. Winkelmayer. (2021) Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney International 100:6, pages 1199-1207.
Crossref
Crossref
Victoria A. Harris, Weining Lin & Stephen J. Perkins. (2021) Analysis of 272 Genetic Variants in the Upgraded Interactive FXI Web Database Reveals New Insights into FXI Deficiency. TH Open 05:04, pages e543-e556.
Crossref
Crossref
Marco Heestermans, Clément Naudin, Reiner K. Mailer, Sandra Konrath, Kristin Klaetschke, Anne Jämsä, Maike Frye, Carsten Deppermann, Giordano Pula, Piotr Kuta, Manuel A. Friese, Mathias Gelderblom, Albert Sickmann, Roger J. S. Preston, Jerzy-Roch Nofer, Stefan Rose-John, Lynn M. Butler, Ophira Salomon, Evi X. Stavrou & Thomas Renné. (2021) Identification of the factor XII contact activation site enables sensitive coagulation diagnostics. Nature Communications 12:1.
Crossref
Crossref
Magdalena Dorota Lewandowska & Jean Marie Connors. (2021) Factor XI Deficiency. Hematology/Oncology Clinics of North America.
Crossref
Crossref
Dominic Beale, Jeremy Dennison, Malcolm Boyce, Francesca Mazzo, Naoki Honda, Paul Smith & Mark Bruce. (2021) ONO‐7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first‐in‐human study. British Journal of Clinical Pharmacology 87:8, pages 3177-3189.
Crossref
Crossref
Jaehyun Kim. (2021) Blood Coagulation Products and Other Hemostatic Agents. The Korean Journal of Blood Transfusion 32:1, pages 11-21.
Crossref
Crossref
Jian MiChaonan Liu, Xunbei Huang, Liqin Ling & Jing Zhou. (2021) Acquired factor XI inhibitor with immune system disorder. Medicine: Case Reports and Study Protocols 2:4, pages e0079.
Crossref
Crossref
Paula H.B. Bolton-Maggs. (2020) A Novel Assay for Determining Bleeding Risk in Factor XI Deficiency. Thrombosis and Haemostasis 121:02, pages 121-121.
Crossref
Crossref
Debora Bertaggia Calderara, Maxime G. Zermatten, Alessandro Aliotta, Ana P. Batista Mesquita Sauvage, Vanessa Carle, Christian Heinis & Lorenzo Alberio. (2020) Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy. Thrombosis and Haemostasis 121:02, pages 150-163.
Crossref
Crossref
Pierre Alex Casthely & Shruthima Thangada. 2021. Essentials of Blood Product Management in Anesthesia Practice. Essentials of Blood Product Management in Anesthesia Practice
121
127
.
Michał B. Ponczek, Aleksandr ShamanaevAlec LaPlaceS. Kent DickesonPriyanka SrivastavaMao-fu Sun, Andras GruberChristian Kastrup, Jonas Emsley & David Gailani. (2020) The evolution of factor XI and the kallikrein-kinin system. Blood Advances 4:24, pages 6135-6147.
Crossref
Crossref
Natasha Parrott & Leigh Kelliher. (2020) A case of factor XI deficiency in a patient undergoing an oesophagogastrectomy. British Journal of Hospital Medicine 81:12, pages 1-2.
Crossref
Crossref
Debora Bertaggia Calderara, Maxime G. Zermatten, Alessandro Aliotta & Lorenzo Alberio. (2020) How to Capture the Bleeding Phenotype in FXI-Deficient Patients. Hämostaseologie 40:04, pages 491-499.
Crossref
Crossref
Shobha Mandal, Sumit Gami & Surendra Shah. (2020) A Case Report on an Extremely Rare Disease: Factor XI Deficiency. Cureus.
Crossref
Crossref
Paul Billoir, Guillaume Feugray, Marie H. Chrétien & Véronique Le Cam Duchez. (2020) Thrombin generation assay is a useful pre‐operative tool to predict non‐bleeding risk in a patient with mild factor V deficiency. Transfusion Medicine 30:5, pages 408-409.
Crossref
Crossref
Priyanka Srivastava & David Gailani. (2020) The rebirth of the contact pathway: a new therapeutic target. Current Opinion in Hematology 27:5, pages 311-319.
Crossref
Crossref
Giacomo Andreani, Lorenzo Uscello, Barbara Montaruli, Antonio Briozzo, Francesco Vitale, Marinella Tricarico, Luisa Arnaldi, Stefania Marengo & Claudio Norbiato. (2020) Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis. TH Open 04:03, pages e233-e235.
Crossref
Crossref
Robert Ariens, Cecilia Becattini, Markus Bender, Wolfgang Bergmeier, Elisabetta Castoldi, Katrien Devreese, Martin Ellis, David Gailani, Vera Ignjatovic, Paula D. James, Steven Kerrigan, Michele Lambert, Lai Heng Lee, Marcel Levi, Norma Maugeri, Joost Meijers, Juan Melero‐Martin, Alan D. Michelson, Federico Mingozzi, Keith Neeves, Heyu Ni, Anna‐Karin Olsson, Zoltán Prohászka, Marie Ranson, Nicoletta Riva, Yotis Senis, Cornelia H. van Ommen, Douglas E. Vaughan & John Weisel. (2020) Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress. Research and Practice in Thrombosis and Haemostasis 4:5, pages 680-713.
Crossref
Crossref
Katarzyna I. Jankowska, Zuben E. Sauna & Chintamani D. Atreya. (2020) Role of microRNAs in Hemophilia and Thrombosis in Humans. International Journal of Molecular Sciences 21:10, pages 3598.
Crossref
Crossref
E.J. Ciampa, N. Liu, J. Stiles, J.L. Carani, Y. Li & P.E. Hess. (2020) Heterozygote carriers of mutations in the F11 gene, encoding Factor XI, have normal coagulation by thromboelastography during pregnancy. International Journal of Obstetric Anesthesia 42, pages 57-60.
Crossref
Crossref
Benjamin GeorgiJohanna MielkeMark ChaffinAmit V. KheraLian GelisHardi MundlJ.J.J. van GiezenPatrick EllinorSekar KathiresanKarl ZiegelbauerDaniel F. Freitag. (2019) Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI. Stroke 50:11, pages 3004-3012.
Crossref
Crossref
Carlos Bravo-Perez, Teresa Ródenas, Julio Esteban, Maria Eugenia de la Morena-Barrio, Salam Salloum-Asfar, Belen de la Morena-Barrio, Antonia Miñano, Vicente Vicente & Javier Corral. (2019) Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study. Medicina Clínica 153:10, pages 373-379.
Crossref
Crossref
Carlos Bravo-Perez, Teresa Ródenas, Julio Esteban, Maria Eugenia de la Morena-Barrio, Salam Salloum-Asfar, Belen de la Morena-Barrio, Antonia Miñano, Vicente Vicente & Javier Corral. (2019) Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study. Medicina Clínica (English Edition) 153:10, pages 373-379.
Crossref
Crossref
Bassem M. Mohammed, Qiufang Cheng, Anton Matafonov, Ingrid M. Verhamme, Jonas Emsley, Keith R. McCrae, Owen J.T. McCarty, Andras Gruber & David Gailani. (2019) A non‐circulating pool of factor XI associated with glycosaminoglycans in mice. Journal of Thrombosis and Haemostasis 17:9, pages 1449-1460.
Crossref
Crossref
David Gailani. (2019) Factor IX for treating factor XI deficiency?. Blood 134:6, pages 501-502.
Crossref
Crossref
Kamran Bakhtiari & Joost C. M. Meijers. (2019) In vitro evaluation of factor IX as novel treatment for factor XI deficiency. Blood 134:6, pages 573-575.
Crossref
Crossref
Xian Li & Jeremy P. Wood. (2019) Studies into prekallikrein activation pave the way for new avenues of antithrombotic research. Journal of Thrombosis and Haemostasis 17:5, pages 717-719.
Crossref
Crossref
Jean Amiral & Jerard Seghatchian. (2019) The contact system at the crossroads of various key patho- physiological functions: Update on present understanding, laboratory exploration and future perspectives. Transfusion and Apheresis Science 58:2, pages 216-222.
Crossref
Crossref
Babbal, Adivitiya, Shilpa Mohanty & Yogender Pal Khasa. 2019. High Value Fermentation Products. High Value Fermentation Products
225
263
.
Robert Silasi, Ravi Shankar Keshari, Cristina Lupu, Walter Janse Van Rensburg, Hala Chaaban, Girija Regmi, Aleksandr Shamanaev, Joseph J. ShatzelCristina Puy, Christina U. Lorentz, Erik I. Tucker, David Gailani, András Gruber, Owen J. T. McCarty & Florea Lupu. (2019) Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death. Blood Advances 3:4, pages 658-669.
Crossref
Crossref
Gloria F. Gerber, Kelsey A. Klute, John Chapin, James Bussel & Maria T. DeSancho. (2019) Peri- and Postpartum Management of Patients With Factor XI Deficiency. Clinical and Applied Thrombosis/Hemostasis 25, pages 107602961988026.
Crossref
Crossref
Benjamin F. Tillman, Andras Gruber, Owen J.T. McCarty & David Gailani. (2018) Plasma contact factors as therapeutic targets. Blood Reviews 32:6, pages 433-448.
Crossref
Crossref
B.M. Mohammed, Q. Cheng, A. Matafonov, D.M. Monroe, J.C.M. Meijers & D. Gailani. (2018) Factor XI promotes hemostasis in factor IX‐deficient mice. Journal of Thrombosis and Haemostasis 16:10, pages 2044-2049.
Crossref
Crossref
Vijaya S. Pilli. 2018. Hematology - Latest Research and Clinical Advances. Hematology - Latest Research and Clinical Advances.
John Puetz, Christopher Hugge & Karen Moser. (2018) Normal aPTT in children with mild factor XI deficiency. Pediatric Blood & Cancer 65:4, pages e26910.
Crossref
Crossref
Bassem M. Mohammed, Anton Matafonov, Ivan Ivanov, Mao-fu Sun, Qiufang Cheng, S. Kent Dickeson, Chan Li, David Sun, Ingrid M. Verhamme, Jonas Emsley & David Gailani. (2018) An update on factor XI structure and function. Thrombosis Research 161, pages 94-105.
Crossref
Crossref
Tahere Tabatabaei & Akbar Dorgalaleh. 2018. Congenital Bleeding Disorders. Congenital Bleeding Disorders
291
306
.
Katrin F. NickelAndy T. LongTobias A. FuchsLynn M. ButlerThomas Renné. (2017) Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases. Arteriosclerosis, Thrombosis, and Vascular Biology 37:1, pages 13-20.
Crossref
Crossref
Ivan Ivanov, Ruhama Shakhawat, Mao-fu Sun, S. Kent Dickeson, Cristina Puy, Owen McCarty, Andras Gruber, Anton Matafonov & David Gailani. (2017) Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen. Thrombosis and Haemostasis 117:04, pages 671-681.
Crossref
Crossref